A critical review on a globally-licensed, live, orally-administrable, monovalent human rotavirus vaccine: Rotarix (Q37547272)

20 August 2017

1 reference

title

A critical review on a globally-licensed, live, orally-administrable, monovalent human rotavirus vaccine: Rotarix (English)

1 reference

20 August 2017

1 reference

Toyoko Nakagomi

1

1 reference

20 August 2017

Osamu Nakagomi

series ordinal

2

1 reference

20 August 2017

language of work or name

English

0 references

publication date

1 August 2009

1 reference

Expert Opinion on Biological Therapy

20 August 2017

published in

1 reference

20 August 2017

volume

9

1 reference

20 August 2017

issue

8

1 reference

20 August 2017

page(s)

1073-1086

1 reference

WHO estimates of the causes of death in children

20 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14712590903103787

Rotavirus and severe childhood diarrhea

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903103787

Issues with reducing the rotavirus-associated mortality by vaccination in developing countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903103787

Burden of rotavirus disease in European Union countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903103787

Virus particles in epithelial cells of duodenal mucosa from children with acute non-bacterial gastroenteritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903103787

Clinical efficacy of the RIT 4237 live attenuated bovine rotavirus vaccine in infants vaccinated before a rotavirus epidemic

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903103787

Failure of live, attenuated oral rotavirus vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903103787

Trial of an attenuated bovine rotavirus vaccine (RIT 4237) in Gambian infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903103787

Rotavirus infection and intussusception: a view from retrospect

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903103787

More on RotaShield and intussusception: the role of age at the time of vaccination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903103787

Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903103787

Rotavirus meningoencephalitis in a previously healthy child and a review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903103787

Rotavirus antigenemia in children with encephalopathy accompanied by rotavirus gastroenteritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903103787

Extended excretion of rotavirus after severe diarrhoea in young children

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903103787

Age-dependent diarrhea induced by a rotaviral nonstructural glycoprotein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903103787

Serotype diversity and reassortment between human and animal rotavirus strains: implications for rotavirus vaccine programs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903103787

Global distribution of rotavirus serotypes/genotypes and its implication for the development and implementation of an effective rotavirus vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903103787

Molecular epidemiology of group A rotavirus diarrhea among children in Buenos Aires, Argentina, from 1999 to 2003 and emergence of the infrequent genotype G12.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903103787

Molecular epidemiology of rotavirus diarrhea among children and adults in Nepal: detection of G12 strains with P[6] or P[8] and a G11P[25] strain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903103787

Molecular and serologic characterization of novel serotype G8 human rotavirus strains detected in Blantyre, Malawi

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903103787

Genomic relationships among rotaviruses recovered from various animal species as revealed by RNA-RNA hybridization assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903103787

Rotavirus infection in infants as protection against subsequent infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903103787

Protection from Rotavirus Reinfection: 2-Year Prospective Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903103787

Rotavirus vaccine introduction in the Americas: progress and lessons learned

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903103787

Lack of association between rotavirus infection and intussusception: implications for use of attenuated rotavirus vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903103787

Comparative evaluation of safety and immunogenicity of two dosages of an oral live attenuated human rotavirus vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903103787

Evaluation of safety, immunogenicity and efficacy of an attenuated rotavirus vaccine, RIX4414: A randomized, placebo-controlled trial in Latin American infants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903103787

Evaluation of RIX4414, a live, attenuated rotavirus vaccine, in a randomized, double-blind, placebo-controlled phase 2 trial involving 2464 Singaporean infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903103787

Protective effect of WC3 vaccine against rotavirus diarrhea in infants during a predominantly serotype 1 rotavirus season

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903103787

Rotarix: a rotavirus vaccine for the world

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903103787

Efficacy of live, attenuated, human rotavirus vaccine 89-12 in infants: a randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903103787

Safety and immunogenicity of RIX4414 live attenuated human rotavirus vaccine in adults, toddlers and previously uninfected infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903103787

Lack of shedding of the RIX4414 live attenuated rotavirus vaccine administered to adult volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903103787

Efficacy and safety of an oral live attenuated human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in Latin American infants: a randomised, double-blind, placebo-controlled phase III study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903103787

Live attenuated human rotavirus vaccine, RIX4414, provides clinical protection in infants against rotavirus strains with and without shared G and P genotypes: integrated analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903103787

Mechanisms of protection against rotavirus infection and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903103787

Rotavirus vaccines: how they work or don't work

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903103787

Possible Mechanisms of Protection Elicited by Candidate Rotavirus Vaccines as Determined with the Adult Mouse Model

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903103787

The human rotavirus vaccine RIX4414 in infants: a review of safety and tolerability

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903103787

Rotavirus vaccines: current prospects and future challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903103787

Apparent extinction of non-G2 rotavirus strains from circulation in Recife, Brazil, after the introduction of rotavirus vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903103787

A critical time for rotavirus vaccines: a review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903103787

A hexavalent human rotavirus-bovine rotavirus (UK) reassortant vaccine designed for use in developing countries and delivered in a schedule with the potential to eliminate the risk of intussusception

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903103787

Rotavirus vaccines: entering a new stage of deployment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903103787

Detection of G12 human rotaviruses in Nepal

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903103787

Efficacy of Two Doses of RIT 4237 Bovine Rotavirus Vaccine for Prevention of Rotavirus Diarrhoea

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903103787

Safety and Efficacy of an Attenuated Vaccine against Severe Rotavirus Gastroenteritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903103787

The expanding diversity of rotaviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903103787

Risk factors for intussusception in infants in Vietnam and Australia: Adenovirus implicated, but not rotavirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903103787

Prevention of Rotavirus Disease: Updated Guidelines for Use of Rotavirus Vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903103787

10.1517/14712590903103787

21 January 2018

Identifiers

DOI

1 reference

20 August 2017

1 reference